glp-1 masld The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis GLP-1 Drugs in MASLD Tied

Resources We Trust Mayo Clinic: Supporting Weight-Loss Medications With Adequate, Tailored Nutrition National Institute of Diabetes and Digestive and Kidney Diseases: Prescription Medications to Treat Overweight & Obesity Massachusetts General Hospital: Fitness for People Taking GLP-1 Agonists: A Comprehensive Guide Cleveland Clinic: This Is How to Lose Weight the Right Way and Keep It Off Yale Medicine: Why Your Cardiologist May Prescribe Semaglutide (Wegovy) Vosoughi K et al

Retatrutide is a new medication (still in development and not FDA-approved for treatment at this stage) that holds promise for helping people manage obesity and other related health issues

Hair Loss Reports What the Data Actually Shows Published TRIUMPH-1 and TRIUMPH-4 readouts have not flagged hair loss as a primary adverse event of interest

We want you to take control

That stands for glucagon-like peptide-1, which is a hormone that we produce in our guts